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ABSTRACT 
Oxidized low-density lipoprotein (ox–LDL) is assumed to be a major causal agent in hypercholesteraemia-
induced atherosclerosis. Because the proliferation of lipid-loaden macrophages within atherosclerotic lesions has 
been described, we investigated the dependence of macrophage proliferation on the inhibition of inducible nitric 
oxide synthase (iNOS) by hypochlorite oxidized LDL. Ox–LDL induces a dose dependent inhibition of induci-
ble nitric oxide synthesis in lipopolysaccharide-interferon stimulated mouse macrophages (J774.A1) with con-
comitant macrophage proliferation as assayed by cell counting, tritiated-thymidine incorporation and measure-
ment of cell protein. Native LDL did not influence macrophage proliferation and inducible nitric oxide synthesis. 
iNOS protein and mRNA was reduced by HOCl-oxidized LDL (0–40 µg/ml) as revealed by immunoblotting and 
competitive semiquantitative PCR. Macrophage proliferation was increased by the addition of the iNOS inhibitor 
L–NAME. The addition of ox–LDL to L–NAME containing incubations induced no further statistically signifi-
cant increase in cell number. Nitric oxide donors decreased ox–LDL induced macrophage proliferation and nitric 
oxide scavengers restored macrophage proliferation to the initial values achieved by ox–LDL. The decrease of 
cytosolic DNA fragments in stimulated macrophages incubated with ox-LDL demonstrates that the proliferative 
actions of ox-LDL are associated with a decrease of NO-induced apoptosis. Our data show that inhibition of iN-
OS dependent nitric oxide production caused by hypochlorite oxidized LDL enhances macrophage proliferation. 
This might be a key event in the pathogenesis of atherosclerotic lesions. 
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INTRODUCTION 
Atherosclerosis is characterized by the 
deposition of lipids and the appearance of 
macrophages in the arterial wall. Oxidized 
LDL (ox–LDL) is assumed to be a major 
causal agent in hypercholesteraemia-induced 
atherosclerosis (Turunen et al., 2014). LDL 
can undergo oxidative modification when in-
cubated in vitro with endothelial cells, 
smooth muscle cells, or macrophages by the 
action of reactive oxygen intermediates, 
macrophage derived myeloperoxidase, or 15-
lipoxygenase activity in endothelial cells. 
Oxidative modification of LDL involves pe-
roxidation of lipids, an increase in the nega-
tive charge of the lipoprotein particles, con-
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version of phosphatidyl-choline to lysophos-
phatidyl-choline, and an alteration of 
epitopes on apolipoprotein B, resulting in its 
recognition and uptake by scavenger recep-
tors on macrophages (Park, 2014). As these 
receptors are not down-regulated by the in-
tracellular cholesterol level, the macrophages 
transform to foam cells (Witztum, 1990). 
Oxidatively modified LDL is present in mac-
rophage foam cells of human atherosclerotic 
lesions (Ylä-Herttuala et al., 1989). The 
dose- and time-dependent inhibition of in-
ducible nitric oxide synthesis by oxidized 
LDL has been shown using mouse macro-
phages activated with IFN-gamma and/or 
LPS (Huang et al., 1999; Yang et al., 1994). 
Innate immune reactions have been de-
scribed for atherosclerotic lesions. LDL is 
involved in vascular inflammatory processes, 
and approaches to new therapies are current-
ly developed based on these concepts of the 
involvement of the immune system in ather-
osclerosis (Hansson and Hermannson, 2011).   
Nitric oxide is synthesized from L-argini-
ne by the L-arginine-nitric oxide pathway 
(Palmer et al., 1988). A family of enzymes, 
termed the nitric oxide synthases (NOS), ca-
talyzes the formation of nitric oxide and cit-
rulline from L–arginine, O2, and NADPH 
(Marletta, 1993). The inducible isoform of 
NOS (NOS–2 or iNOS, EC 1.14.13.39) gen-
erates large amounts of NO over a prolonged 
period of time through a Ca2+ independent 
pathway (Xie et al., 1992). Inducible NOS 
expression has been observed in many cells, 
including murine macrophages (Hibbs et al., 
1988). NO inhibits proliferation of vascular 
smooth muscle cells, mesangial cells, cancer 
cells, and fibroblasts (Cheng et al., 2014).  
Because the local proliferation of macro-
phages has been revealed as a key event in 
atherosclerosis (Robbins et al., 2013; Rosen-
feld and Ross, 1990), and in situ hybridisa-
tion confirmed the presence of iNOS in mac-
rophages, foam cells, and vascular smooth 
muscle cells of atherosclerotic vessels (But-
tery et al., 1996), we investigated the correla-
tion between the inhibition of inducible nitric 
oxide synthesis by oxidatively modified 
LDL and macrophage proliferation.  
 
MATERIALS AND METHODS 
Materials  
[3H]L-arginine (68 Ci/mmol) was sup-
plied by Amersham Corp., Arlington 
Heights, IL. [3H]thymidine (20 Ci/mmol) 
was obtained from ICN Pharmaceuticals, 
Costa Mesa, CA. Recombinant mouse gam-
ma interferon (IFN–gamma) was purchased 
from Gibco BRL, Gaithersburg, MD. 2,2'–
(Hydroxynitrosohydrazino) bis-etanamine 
(NOC 18) and 2–(4–Carboxyphenyl)-
4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxi-
de (carboxy–PTIO) were obtained from 
Dojindo Laboratories, Tokyo, JP. Rabbit an-
ti–iNOS polyclonal antibody and purified 
iNOS protein was supplied by Calbiochem, 
San Diego, CA. Cell culture materials, Esch-
erichia coli lipopolysaccharide serotype 
055:B5 (LPS) and all other chemicals were 
obtained from Sigma Chemical Co., St. Lou-
is, MO. 
 
Cell culture  
The mouse monocyte/macrophage cell 
line J774.A1 (ATCC TIB 67) was cultured in 
Dulbecco´s Modified Eagle´s Medium 
(DMEM) supplemented with 10 % FBS, 
25 mM HEPES, 2 mM Glutamine, 100 U 
penicillin/ml and 100 µg streptomycin/ml at 
37 °C, 5 % CO2, and 95 % humidity. Cells 
were studied between passages 7-30. Prior to 
the experiments cells were cultured for 24 
hours with lipoprotein deficient serum 
(LPDS). Thereafter, cells were seeded in 24-
well dishes at a density of 2 x 105 cells/well, 
stimulated by the addition of IFN–gamma 
(10 U/ml) and LPS (1 µg/ml), and incubated 
either with or without the indicated lipopro-
teins for 24 hours.  
 
Nitrite analysis  
Nitrite was determined spectrophotomet-
rically by using the Griess reagent (0.5 % 
sulfanilic acid, 0.002 % N-1-naphtyl-ethyl-
enediamine dihydrochloride, 14 % glacial 
acetic acid) in supernatants. Absorbance was 
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measured at 550 nm with baseline correction 
at 650 nm and nitrite concentration was de-
termined using sodium nitrite as a standard 
(Green et al., 1982).  
 
Measurement of citrulline synthesis as a 
marker of NO production  
iNOS activity was determined by the 
conversion of arginine to citrulline. Citrul-
line was measured by a radiometric method 
as described previously (Bredt and Snyder, 
1989). IFN-gamma/LPS stimulated J774.A1 
mouse macrophages were incubated at 37 °C 
with [3H]L-arginine (0.5 µCi/ml) for 15 
minutes. The reaction was stopped by wash-
ing cells with cold phosphate-buffered sa-
line. To separate [3H]L-citrulline from [3H]L-
arginine, Dowex resin (AG 50W-X8, sodium 
form, Bio-Rad Lab., Richmond, CA, USA) 
was added to the cell lysates. The resin was 
allowed to settle for 15 minutes. Aliquots of 
the supernatants were used for liquid scintil-
lation counting. [3H]L-citrulline formation 
was expressed as counts per minute (cpm) 
per mg cell protein above basal levels meas-
ured in unstimulated macro-phages.  
 
Preparation and oxidation of LDL  
LDL (relative density 1.019 to 1.063 
g/ml) was isolated from human plasma by 
sequential ultracentrifugation and was flotat-
ed through a potassium bromide solution of 
d=1.063 g/ml. After centrifugation LDL was 
filtered (0.45 µm pore size) and used imme-
diately for further modification. LDL was 
transferred into PBS containing 100 µM 
EDTA by gel filtration through a size exclu-
sion column (Bio-Rad Econo–Pac 10DG). 
The preparation of hypochlorite oxidized 
LDL was performed as described previously 
(Arnhold et al., 1991) with minor modifica-
tions. The molar excess of hypochlorite over 
LDL was in the range of 400-600. After al-
lowing the hypochlorite reagent to react with 
LDL for 15 min on ice, LDL was again 
passed over a size exclusion column (Bio-
Rad 10DG) equilibrated with PBS contain-
ing 100 µM EDTA to remove excess rea-
gent. Agarose gel electrophoresis of hypo-
chlorite (HOCl) ox-LDL particles revealed 
an about twofold increase of the relative 
electrophoretic mobility. For the preparation 
of lipoprotein deficient serum (LPDS) fetal 
calf serum (Sigma) was depleted of lipopro-
teins by flotation at 100 000g with a density 
of 1.21 g/ml for 48 hours. After flotation the 
lipoprotein deficient serum was excessively 
dialyzed against saline and sterile filtered 
(0.22 µm pore size).  
 
Tritiated thymidine incorporation  
Macrophage growth was assayed by the 
incorporation of [3H]thymidine (20 Ci/ 
mmol) into cellular DNA. [3H]thymidine 
(1 µCi/well) was added directly to the cul-
ture medium for the last two hours of an in-
cubation. The medium was aspirated and the 
cells were washed with 500 µl ice-cold 
phosphate-buffered saline on ice before the 
addition of 500 µl methanol. Cell DNA was 
precipitated by adding 500 µl of 10 % tri-
chloroacetic acid. Precipitates were lysed 
with 200 µl of 300 mM sodium hydroxide 
containing 1 % sodium dodecyl sulphate. 
Samples were aspirated and subjected to liq-
uid scintillation counting.  
 
Arginine transport  
Arginine uptake by macrophages was 
measured by adding [3H]L-arginine (68 
Ci/mmol, 0.2 µCi/well) directly to the medi-
um after a 24 hours incubation with or with-
out ox–LDL as indicated. After 60 minutes 
the medium was aspirated and the cells were 
washed twice with 500 µl ice-cold phos-
phate-buffered saline. Cells were lysed with 
200 µl of 300 mM sodium hydroxide con-
taining 1 % sodium dodecyl sulphate. Sam-
ples were aspirated and subjected to liquid 
scintillation counting.  
 
Cell number determination  
To determine the number of J774.A1 
cells during culture, the number of adherent 
cells was counted within standard-sized are-
as (0.25 mm2) in each of three wells by in-
verted phase-contrast microscopy.  
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Cell protein  
Protein was determined according to the 
method of Bradford (Bradford, 1976) using 
bovine serum albumin as standard. 
 
Western blotting for inducible nitric oxide 
synthase  
Cells were lysed in ice-cold buffer con-
taining 25 mM monosodium phosphate (pH 
7.4), 75 mM NaCl, 5 mM EDTA, 1 % Triton 
X-100, 100 µg/ml phenylmethylsulfonylfluo-
ride, 10 µg/ml antipain, 10 µg/ml leupeptin, 
10 µg/ml pepstatin, 20 µg/ml aprotinin, and 
10 µg/ml trypsin inhibitor and centrifuged at 
50 000g for 20 minutes at 4 °C. The cyto-
solic proteins (12 µg per lane) were separat-
ed by 8 % SDS-polyacrylamide gel electro-
phoresis. Proteins were transferred to nitro-
cellulose filters, and then immunoblotted 
with a rabbit anti-iNOS polyclonal antibody 
at a 1:1000 dilution. Anti-rabbit horseradish 
peroxidase-conjugated antibody was used as 
a secondary antibody at a dilution of 1:2500. 
The blots were detected with the enhanced 
chemiluminescence method and exposed to 
photographic film.  
 
Semiquantitative competitive RT-PCR  
Total RNA was isolated using the guani-
dinium thiocyanate method (Chomczynski 
and Sacchi, 1987). To determine the RNA 
concentration the absorption at 260, 280, and 
320 nm was measured photometrically 
(UV/VIS Spectrophotometer Lambda 2, Per-
kin-Elmer, Norwalk, CT). Single-stranded 
cDNA synthesis was carried out on 2 µg of 
total RNA primed with oligo(dT)12-18 (Phar-
macia, Freiburg, Germany) using murine 
leukemia virus reverse transcriptase 
(MMLV-RT; MBI Fermentas, Vilnius, Lith-
uania) at 37 °C for 60 min. Reactions were 
stopped by heating for 5 min at 70 °C. iNOS 
cDNA was subjected to DNA amplification 
by PCR using 0.5 units of Taq DNA polyme-
rase (MBI) with oligonucleotide primers 
complementary to murine iNOS cDNA 
(MWG-Biotec, Ebersberg, Germany) at a fi-
nal concentration of 0.25 µM. Oligonucleo-
tide primers against beta-actin were used as 
the competitor at a concentration of 
0.03 µM. Reaction mixtures were subjected 
to the following conditions in a PE 2400 
DNA thermal cycler (Perkin–Elmer): dena-
turing at 94 °C for 30 seconds, annealing at 
55 °C for 35 seconds, and extension at 72 °C 
for 35 seconds. After 32 cycles, the reaction 
mixture was cooled down to 4 °C. The pri-
mers for iNOS were 5´–CTA AGA GTC 
ACC AAA ATG GCT CCC–3´ (sense) and 
5´–ACC AGA GGC AGC ACA TCA AAG 
C–3´ (antisense). The expected product 
length was 775 bp. The following primers 
for the “housekeeping gene” beta–actin were 
used: 5´–ATG GTG GGA ATG GGT CAG 
AAG GAC–3´(sense) and 5´–CTC TTT 
GAT GTC ACG CAC GAT TTC–3´ (anti-
sense). The expected product length was 513 
bp. All PCR-reactions were in linear range. 
Final PCR products were separated on a 
1.2 % agarose gel and detected by ethidium 
bromide staining. Semiquantitative estima-
tion was done by comparing mRNA expres-
sion of iNOS to beta–actin represented by 
the amount of the PCR product formed.  
 
DNA fragmentation assay  
Cytosolic DNA fragments were quanti-
fied by a cell death detection ELISA 
(Boehringer Mannheim, Mannheim, Germa-
ny). The assay is based on the sandwich-
enzyme-immunoassay principle using mouse 
monoclonal antibodies directed against his-
tone-associated-DNA-fragments. Cells were 
washed with phosphate buffered saline and 
lysed with ELISA buffer. The lysates were 
centrifuged at 200 g for 10 min. The histone-
associated-DNA-fragments of the superna-
tant were linked to the biotinylated anti-
histone antibody bound to the streptavidin-
coated microtiter plate as described by the 
manufacturer. The DNA-part of the nucleo-
somes was detected by peroxidase labelled 
anti-DNA antibody. The amount of histone-
associated-DNA-fragments was quantified 
spectrophotometrically with 2,2´-azino-di(3-
ethylbenzthiazolin-sulfonate) as substrate. 
Samples were read at 405 nm and 492 nm on 
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a Perkin-Elmer Lambda 2 Spectrophotome-
ter. 
 
Data analysis  
Each experimental result as shown in the 
figures is the mean ± SD for at least three 
measurements. When SD is not displayed, it 
is smaller than the size of the symbol. Statis-
tical analyses were performed by use of 
ANOVA followed by Student´s t-tests for 
unpaired data. Statistical significance was 
defined as P < 0.05. 
 
RESULTS 
Inhibition of inducible nitric oxide synthe-
sis by ox–LDL  
Activated J774.A1 cells released large 
amounts of nitrite into the culture medium 
(36 ± 2.9 nmol nitrite per mg protein within 
24 hours). Incubation of activated J774.A1 
cells with oxidized LDL was associated with 
a dose dependent reduction in NO produc-
tion (Figure 1). Incubations with native LDL 
revealed no inhibition of NO synthesis. To 
confirm our results that inducible nitric oxide 
synthesis is reduced by oxidized LDL, iNOS 
activity was determined by the conversion of 
arginine to citrulline described in the 
METHODS section. Citrulline formation 
was reduced by ox–LDL in a dose dependent 
manner from 380 ± 47.1 cpm/mg protein for 
control incubations of activated J774.A1 
macrophages without ox–LDL to 206 ± 20.1 
cpm/mg protein for 10 µg/ml ox–LDL, 77.1 
± 80.8 cpm/mg protein for 20 µg/ml ox–
LDL, and 34.5 ± 33.4 cpm/mg protein for 
40 µg/ml ox–LDL. Measurements of cyto-
toxicity were performed since toxic effects 
of ox–LDL towards various cell species have 
been described. Up to a concentration of 50 
µg/ml ox–LDL or native LDL respectively, 
cell viabilities were > 95 % as measured by 
trypan blue exclusion.  
 
Effects of ox–LDL on arginine transport  
To investigate whether ox–LDL induced 
inhibition of NO production was associated 
with a decreased arginine uptake, J774.A1 
cells were incubated with [3H]L-arginine as 
described in METHODS. Arginine transport 
into the cells was not significantly reduced 
when incubated with increasing amounts (0-
50 µg/ml ox–LDL f.c., data not shown). It 
can be concluded that ox–LDL induced inhi-
bition of inducible NO synthesis is not a 
consequence of reduced cellular arginine up-
take.  
 
Effects of ox-LDL on iNOS mRNA  
expression  
Figure 2 shows the competitive semi-
quantitative RT-PCR analysis of iNOS 
mRNA in J774.A1 cells. iNOS mRNA (775 
bp) showed a dose dependent reduction 
when cells were incubated with increasing 
amounts of ox–LDL (lanes 1-5). Native LDL 
(20 µg/ml; lane 6) did not reduce iNOS 
mRNA levels. Actin mRNA (513 bp) levels 
remained unchanged. Our data show that 
HOCl-oxidized LDL, but not native LDL, 
decreases iNOS mRNA levels.  
 
Figure 1: Dose-dependent inhibition of nitric ox-
ide production by HOCl oxidized low-density lip-
oprotein (ox–LDL) in J774.A1 macrophages. Cell 
monolayers were preincubated with DMEM con-
taining 10 % lipoprotein-deficient serum for 24 
hours. Thereafter, cells were activated with 10 
U/ml IFN-gamma and 1 µg/ml LPS and incubat-
ed with increasing amounts (0-50 µg/ml f.c.) of 
oxidized (•) or native (o) LDL as indicated for 24 
hours. After 24 hours the culture media were col-
lected and assayed for nitrite as described in 
METHODS. Each data point shows the mean of 
triplicate measurements. Error bars show the 
standard deviation. P was < 0.01 or smaller for 
any ox–LDL containing incubations when com-
pared to controls without ox–LDL. Differences 
between the incubations containing native LDL 
were not statistically significant. 
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Figure 2: Effects of HOCl-oxidized LDL on iNOS 
mRNA expression (semiquantitative RT–PCR). 
J774.A1 mouse macrophages were cultured in 
lipoprotein–deficient medium for 24 hours fol-
lowed by an incubation with 0–40 µg/ml HOCl-
oxidized LDL or 20 µg/ml native LDL and IFN–
gamma/LPS for 24 hours. RNA was extracted 
and analyzed as described in the METHODS 
section, single-stranded cDNA synthesis was 
performed, and DNA was amplified by semiquan-
titative competitive PCR using specific primers 
for iNOS and actin. iNOS mRNA (775 bp) 
showed a dose dependent reduction when cells 
were incubated with increasing amounts (0-40 
µg/ml) of ox–LDL (lanes 1-5). Native LDL (lane 
6) did not reduce iNOS mRNA levels. Actin 
mRNA (513 bp) levels remained unchanged. Da-
ta shown are representative for three independ-
ent experiments.  
 
 
Effects of ox–LDL on iNOS protein expres-
sion  
Figure 3 shows the Western blot analysis 
of inducible nitric oxide synthase in J774.A1 
cells. IFN-gamma/LPS stimulated J774.A1 
mouse macrophages were incubated with 
with increasing amounts (0–40 µg/ml) of 
HOCl-oxidized LDL or native LDL (20 
µg/ml) for 24 hours. Western blotting was 
performed as described in the METHODS 
section.  
 
Effects of ox–LDL on macrophage growth  
Tritiated thymidine incorporation was 
determined in IFN-gamma/LPS stimulated 
and unstimulated cells to examine whether 
inhibition of inducible nitric oxide synthesis 
by ox–LDL stimulates proliferation of 
J774.A1 macrophages. iNOS induction by 
IFN-gamma/LPS reduced basal tritiated 
thymidine incorporation of J774.A1 cells by 
more than 95 %. The inhibition of basal triti-
ated thymidine incorporation was antago-
nized by ox–LDL. As shown in Figure 4, 
tritiated thymidine uptake increased 21.5-
fold after a 24 hour incubation with 20 µg/ml 
ox–LDL for stimulated cells. The increase of 
tritiated thymidine incorporation was linear 
in a dose-dependent manner up to 20 µg/ml 
ox–LDL for IFN-gamma/LPS stimulated 
macrophages. When incubated with more 
than 50 µg/ml ox–LDL thymidine incorpora-
tion decreased probably due to cytotoxic ef-
fects of ox–LDL on macrophages.  
The correlation between inhibition of in-
ducible nitric oxide synthesis by ox–LDL 
and increased thymidine incorporation was 
linear from 0-20 µg/ml ox–LDL with a cor-
relation coefficient of 0.98. The slight (1.5-
fold) increase of tritiated thymidine incorpo-
ration after a 24 hour incubation with native 
LDL (20 µg/ml) was not statistically signifi-
cant. Incubations of unstimulated cells with 
0-20 µg/ml ox–LDL showed a 2.75-fold in-
crease of tritiated thymidine incorporation 
after 24 hours (data not shown). These re-
sults suggest that the inhibition of inducible 
nitric oxide synthesis by ox–LDL has the ca-
pability to augment growth (i.e., increase in 
cell number) of IFN-gamma/LPS stimulated 
J774.A1 macrophages.  
 
 
Figure 3: Immunoblotting against inducible nitric 
oxide synthase. J774.A1 mouse macrophages 
were cultured in lipoprotein–deficient medium for 
24 hours, stimulated with IFN-gamma/LPS, and 
incubated with increasing amounts (0–40 µg/ml) 
of HOCl-oxidized LDL or native LDL (20 µg/ml) 
for 24 hours. Western blotting was performed as 
described in the METHODS section. Immunob-
lotting identified a band with an estimated mo-
lecular mass of 130 kD, the known molecular 
mass of inducible nitric oxide synthase, in stimu-
lated J774.A1 mouse macrophages. iNOS pro-
tein showed a dose dependent reduction when 
cells were incubated with increasing amounts (0–
40 µg/ml) of ox–LDL. Native LDL did not reduce 
iNOS protein levels. Actin (43 kD) levels re-
mained unchanged during incubations with ox–
LDL. Data shown are representative for three in-
dependent experiments.  
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To prove this notion the number of 
macrophages per well was determined by 
inverted phase-contrast microscopy (cell 
counting). The results show an increased cell 
proliferation after a 24 hour incubation with 
0-50 µg/ml ox–LDL for IFN-gamma/LPS 
stimulated macrophages (Figure 5).  
Cell number increased from 2.78 ± 0.2 x 
105 cells/well for control incubations without 
LDL to 3.29 ± 0.21 x 105 cells/well for 20 
µg/ml ox–LDL and 3.32 ± 0.18 x 105 
cells/well for 50 µg/ml ox–LDL (P < 0.05). 
Native LDL had no significant effect on cell 
number (2.83 ± 0.21 x 105 cells/well for con-
trol incubations without LDL against 2.76 ± 
0.12 x 105 cells/well for 20 µg/ml native 
LDL and 2.82 ± 0.12 x 105 cells/well for 
50 µg/ml native LDL; differences not statis-
tically significant).  
To prove that ox–LDL induced prolifera-
tion is a consequence of iNOS inhibition, 
J774.A1 mouse macrophages were seeded at 
a density of 2 x 105 per well, stimulated with 
IFN-gamma/LPS, and cultured  with  HOCl- 
 
 
Figure 4: Effects of ox–LDL and native LDL on 
the proliferation of IFN-gamma/LPS stimulated 
macrophages. J774.A1 monocyte/macrophages 
were preincubated with DME medium containing 
10 % LPDS for 24 hours. Cells were stimulated 
with IFN-gamma/LPS and incubated with in-
creasing amounts (0-20 µg/ml f.c.) of oxidized 
LDL (•) or native LDL (o) for 24 hours. Cell prolif-
eration was measured as tritiated thymidine 
([3H]thymidine) incorporation into macrophages 
as described in METHODS. Data show the mean 
of triplicate measurements ± SD and are repre-
sentative of three independent experiments.  
oxidized LDL (0–50 µg/ml), or with ox–
LDL and 300 µM of the nitric oxide synthase 
inhibitor L–NAME for 24 hours. The addi-
tion of L-NAME to stimulated macrophages 
increased the cell number from 2.01 ± 0.04 x 
105 cells/well (control incubations without L-
NAME) to 3.12 ± 0.35 x 105 cells/well. This 
was accompanied by an almost complete in-
hibition of NO synthesis. The addition of 
HOCl-oxidized LDL (0-50 µg/ml) to L-
NAME containing incubations induced no 
further statistically significant increase in 
cell number (data not shown). This shows 
that ox–LDL induced proliferation of stimu-
lated macrophages is a consequence of iNOS 
inhibition. 
 
Effect of nitric oxide on ox–LDL induced 
macrophage proliferation  
We next examined whether the increased 
macrophage proliferation could be antago-
nized by the addition of nitric oxide donors 
(NOC 18) and if the antiproliferative actions 
 
 
Figure 5: Ox–LDL induced increase of cell num-
ber. J774.A1 monocyte/macrophages were pre-
incubated with DME medium containing 10 % 
LPDS for 24 hours. Cells were stimulated with 
IFN-gamma/LPS and incubated with increasing 
amounts (0-50 µg/ml f.c.) of oxidized LDL for 24 
hours. Cell counting was performed by phase-
contrast microscopy as described in METHODS 
and is shown as cell number x 105 per well. Data 
show the mean of triplicate measurements ± SD 
and are representative of three independent ex-
periments. *P < 0.05 compared to control incuba-
tions without ox–LDL. 
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of nitric oxide could be reversed by nitric ox-
ide scavengers (carboxy-PTIO, hemoglobin). 
Figure 6 shows the increased proliferation of 
IFN-gamma/LPS stimulated macrophages by 
10 µg/ml ox–LDL in vitro as quantified by 
cell counting after a 24 hours incubation.  
In addition, measurements of thymidine 
incorporation and cell protein were per-
formed as described in METHODS. Correla-
tion between the means of thymidine incor-
poration and cell count was linear with a cor-
relation coefficient of 0.92. Correlation be-
tween the means of cell protein and cell 
count was linear with r = 0.93. 
 
 
 
Figure 6: Bar chart showing the effect of nitric 
oxide donors and ox–LDL on macrophage 
growth in vitro as quantified by cell counting. 
Cells were prepared as described in METHODS. 
IFN-gamma/LPS stimulated J774.A1 mouse 
macrophages were seeded at a density of 2 x 
105 per well and cultured with or without 10 µg/ml 
HOCl-oxidized LDL for 24 hours. Ox–LDL in-
duced proliferation was inhibited by the NO do-
nor NOC 18 (30 µg/ml; P<0.0001). The inhibition 
of cell proliferation could be antagonized by add-
ing NO scavengers carboxy-PTIO (10 and 20 
µg/ml; P<0.005) and oxygenated hemoglobin 
(100 µM HbO2; P<0.005). Values are given as 
cell number x 105 per well. Error bars represent 
SD of triplicate measurements. 
 
 
Effects of ox-LDL and nitric oxide on mac-
rophage apoptosis  
NO mediated apoptosis has been de-
scribed for various cell lines (Cheng et al. 
2014). To test if ox-LDL mediated inhibition 
of inducible nitric oxide synthesis prevents 
apoptosis in J774.A1 macrophages we as-
sessed cytosolic DNA fragments as de-
scribed in METHODS.  
The decrease of cytosolic DNA frag-
ments in stimulated macrophages incubated 
with ox-LDL shows that the proliferative ac-
tions of ox-LDL are associated with a de-
crease of NO-induced apoptosis (Figure 7).  
 
 
 
Figure 7: Inhibition of inducible nitric oxide syn-
thesis by ox-LDL prevents apoptosis in J774.A1 
macrophages. Apoptosis was quantified by de-
tection of histone-associated-DNA-fragments as 
described in METHODS. Stimulated J774.A1 
mouse macrophages were cultured in lipopro-
tein-deficient medium for 24 hours followed by an 
incubation with or without 10 µg/ml HOCl-
oxidized LDL for 24 hours. Ox-LDL inhibits the 
apoptosis of macrophages expressing iNOS ac-
tivity (P < 0.0005). Decreased DNA-fragment-
ation by ox-LDL was increased by the NO donor 
NOC 18 (30 µg/ml; P < 0.005). The nitric oxide 
mediated increase in apoptosis could be antago-
nized by adding the NO scavengers carboxy-
PTIO (20 µg/ml; P < 0.02) and oxygenated he-
moglobin (100 µM HbO2; P < 0.02). Error bars 
represent SD.  
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DISCUSSION 
The present study shows a correlation be-
tween macrophage growth and the inhibition 
of inducible nitric oxide synthase by ox–
LDL. The inhibition of iNOS by copper-
oxidized LDL has been demonstrated 
(Matsuno et al., 1997; Yang et al. 1994). Ox-
idative modification of LDL results in the 
formation of lipid hydroperoxides and pro-
motes atherosclerosis (Fan et al., 2014). The 
inhibition of iNOS by the lipid hydroperox-
ide 13–hydroperoxyl octadecadienoic (13-
HPODE) acid has been previously described 
(Huang et al., 1999). During our experiments 
hypochlorite (HOCl) oxidized LDL was used 
because its physiological relevance has been 
emphasized (Hazell et al., 1996), and the oc-
currence of copper-oxidized LDL in vivo has 
not yet been confirmed. HOCl is an oxidant 
produced from H2O2 and chloride by 
myeloperoxidase (MPO, E.C. 1.11.1.7) in 
vivo. MPO is present in its active form in 
human atherosclerotic lesions (Daugherty et 
al., 1994). HOCl aggregates and transforms 
LDL into a high-uptake form for macro-
phages in vitro. Using monoclonal antibodies 
HOCl-oxidized proteins have been demon-
strated in human atherosclerotic lesions and 
were predominantly found in mono-
cyte/macrophages, smooth muscle cells, and 
endothelial cells (Hazell et al., 1996). Prolif-
eration of macrophages within atherosclerot-
ic lesions has been shown (Robbins et al., 
2013), and in situ hybridisation confirmed 
the presence of iNOS in macrophages, foam 
cells, and vascular smooth muscle cells of 
atherosclerotic vessels (Buttery et al., 1996). 
On the basis of a recent report showing a 
lower percentage of proliferating macro-
phages in early plaques compared with ad-
vanced plaques, it seems to be variable in 
different stages of the disease (Robbins et 
al., 2013).  
Contradictory results have been reported 
regarding an ox–LDL induced iNOS inhibi-
tion and a decrease of iNOS mRNA. Both 
transcriptional mechanisms with an ox–LDL 
associated decrease of iNOS mRNA synthe-
sis (Hamilton et al., 1995; Huang et al., 
1999) and posttranscriptional mechanisms of 
ox–LDL induced iNOS inhibition without 
significant effects of ox–LDL towards iNOS 
mRNA levels (Wu et al., 1998; Yang et al. 
1994) have been postulated. According to 
our data, iNOS mRNA is reduced in a dose 
dependent manner after an incubation of 
J774.A1 mouse macrophages with increasing 
amounts (0-40 µg/ml) of HOCl-oxidized 
LDL. In contrast, native LDL did not reduce 
iNOS mRNA levels. Actin mRNA levels 
remained unchanged, thereby excluding tox-
ic effects of HOCl-oxidized LDL. The de-
crease of iNOS mRNA was associated with a 
dose-dependent decrease of iNOS protein, as 
revealed by immunoblotting.  
Formation of nitric oxide by the constitu-
tive NOS expressed in endothelial cells is 
believed to protect against the development 
of atherosclerotic lesions. Under conditions 
with decreased constitutive NOS activity, 
iNOS might substitute the synthesis of NO 
(Kanno et al., 2000; Yan et al., 1996). iNOS 
expression within macrophages of athero-
sclerotic lesions has been described. Previ-
ous studies were conducted on normal and 
atherosclerotic human vessels by in situ hy-
bridisation and immuno-histochemistry us-
ing probes for iNOS. Inducible NOS was not 
detected in normal vessels but widespread 
iNOS protein staining was found in early and 
advanced lesions in macrophages, foam 
cells, and vascular smooth muscle cells of 
atherosclerotic vessels (Baker et al., 1999; 
Buttery et al., 1996). Inhibition of iNOS by 
ox–LDL might contribute to the develop-
ment of atherosclerotic plaques by an in-
creased proliferation of macrophages due to 
the diminished release of antiproliferative ni-
tric oxide in these lesions. 
iNOS expression in vascular smooth 
muscle cells and macrophages may be bene-
ficial as a compensatory mechanism for the 
lack of endothelial NO synthesis (Kanno et 
al., 2000; Yan et al., 1996), thereby prevent-
ing restenosis following angioplasty or heart 
transplant vasculopathy (Hecker et al., 
1999). This idea is supported by a paper, 
showing that the administration of an iNOS 
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selective inhibitor L–N6–(1–iminoethyl)–
lysine accelerated the progression of vascu-
lopathy in transplantation atherosclerosis, 
and transduction with iNOS using an adeno-
viral vector has been shown to completely 
suppress the development of allograft arteri-
osclerosis (Forbes et al., 2013; Shears et al., 
1997). Induction of iNOS leads to a reduced 
proliferation in both medial and intimal 
smooth muscle cells (Yan and Hansson, 
1998) and iNOS was shown to restore blood 
flow in the injured artery after denudation of 
the rat carotid artery as a model for arterial 
injury and restenosis (Yan et al., 1996). iN-
OS gene transfer to rats and pigs has been 
shown to inhibit intimal hyperplasia in re-
sponse to vascular injury in vivo. This pro-
tective effect was reversed by selective iNOS 
inhibition (De Meyer et al., 2000; Shears et 
al., 1998). A higher incidence of atheroscle-
rotic plaques, an elevated systolic blood 
pressure, and increased serum cholesterol 
levels have been described for iNOS defi-
cient mice (Ihrig et al., 2001). Immunohisto-
chemical evaluations of atherosclerotic le-
sions from iNOS knockout mice have shown 
activated endothelial cells and lipid-loaden 
macrophages (foam cells), and oxidized low-
density lipoprotein immune complexes, sug-
gesting that advanced vascular disease in 
iNOS knockout mice can be mediated by in-
creased accumulation of oxLDL immune 
complexes (Al Gadban et al., 2012). Accord-
ing to these results, inducible nitric oxide 
synthesis can be supposed to be a compensa-
tory mechanism for the lack of endothelial 
NO formation, thereby maintaining vascular 
homeostasis.  
Myogenic and macrophagic foam cells 
are commonly detected in experimental and 
human fibro-atheromatous plaques. In a 
thymidine-autoradiographic study combined 
with ultrastructural observations in the hu-
man fibro-atheromatous plaques most of the 
autoradiographic silver grains appeared on 
foam cells and monocyte-like cells, thus 
suggesting a local proliferation of these cells 
(Villaschi and Spagnoli, 1983). Simultane-
ous thymidine autoradiography and im-
munostaining with cell type-specific mono-
clonal antibodies revealed that approximate-
ly 30 % of the labeled cells were macro-
phages and 45 % were smooth muscle cells 
in advanced atherosclerotic lesions (Rosen-
feld and Ross, 1990). Increased macrophage 
proliferation resulting from a decrease of 
iNOS dependent nitric oxide production 
might enhance the development of athero-
sclerotic lesions.  
Cytokines such as IFN-gamma have pre-
viously been shown to inhibit DNA synthe-
sis, cell growth and division by a NO-
dependent mechanism (Garg and Hassid, 
1989). In addition, induction of iNOS by 
IFN-gamma and LPS was associated with an 
increase in apoptosis of murine peritoneal 
macrophages (Albina et al., 1993). Nitric ox-
ide synthesis by iNOS correlates inversely 
with macrophage life span in vitro. It has 
been proposed that NO-dependent death of 
murine peritoneal macrophages activated in 
vitro with IFN-gamma and LPS is mediated 
through apoptosis. This was shown by mi-
croscopic examination of the cells, which re-
vealed the presence of nuclear and cytoplas-
mic alterations characteristic of apoptosis, 
and by the specific pattern of internucleoso-
mal DNA fragmentation detected by electro-
phoresis (Albina et al., 1993). Nitric oxide 
induced apoptosis is presumed to be due to 
cyclic GMP dependent protein kinase G ac-
tivation (Loweth et al., 1997). Inhibition of 
NO formation by N-monomethyl-L-arginine 
(L-NMA) diminished apoptosis of IFN-
gamma/LPS activated J774.A1 macrophages 
(Yang et al., 1996). Our data indicate that 
inhibition of iNOS dependent nitric oxide 
production by oxidized LDL enhances mac-
rophage proliferation and is associated with 
diminished NO-mediated apoptosis.  
Inducible nitric oxide synthesis blocks 
cell proliferation via a cGMP dependent 
pathway (Shears et al., 1998), and independ-
ent of cGMP through the p42/44 mitogen-
activated protein kinase (MAPK) signaling 
cascade with upregulation of the cell cycle 
inhibitor p21 (Kibbe et al., 2000). In addition 
to a local proliferation, the appearance of 
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macrophages within atherosclerotic lesions 
has been supposed to be the consequence of 
an increased recruitment of monocytes via 
NF-kappa B dependent expression of vascu-
lar endothelial cell adhesion-molecule 1 
(VCAM–1), macrophage-colony-stimulat-
ing-factor (M–CSF), and monocyte chemoat-
tractant protein 1 (MCP–1) by human vascu-
lar endothelial cells. NO has been shown to 
inhibit VCAM–1 (De Caterina et al., 1995), 
M–CSF (Peng et al., 1995), and MCP–1 ex-
pression (Zeiher et al., 1995) by inhibiting 
NF–kappa B activation. Inhibition of NO 
synthesis by L–NMA was shown to activate 
NF–kappa B with concomitant VCAM–1, 
M–CSF, and MCP–1 expression (De Cateri-
na et al. 1995; Peng et al. 1995; Zeiher et al. 
1995). Inhibition of inducible nitric oxide 
synthesis by ox–LDL might influence mac-
rophage accumulation within atherosclerotic 
lesions by enhancing NF-kappa B dependent 
VCAM–1, M–CSF, and MCP–1 expression.  
Numerous anti-atherogenic properties of 
nitric oxide in vitro have been described. NO 
inhibits LDL oxidation (Hogg et al., 1995), 
smooth muscle cell proliferation (Garg and 
Hassid, 1989), smooth muscle cell migration 
(Dubey et al., 1995), neutrophil adhesion 
(Lefer and Ma, 1993), MCP-1 expression 
(Zeiher et al., 1995), and inhibits NF-kappa 
B activation (Peng et al., 1995; Zeiher et al., 
1995). Using IFN-gamma/LPS stimulated 
macrophages we examined the influence of 
iNOS antagonists (L-NAME), nitric oxide 
donors (NOC 18), and nitric oxide scaven-
gers (carboxy-PTIO, hemoglobin) on ox–
LDL induced macrophage proliferation. Our 
results contribute to the concept that induci-
ble NO release can protect against athero-
genesis by preventing macrophage prolifera-
tion and ox–LDL might contribute to the de-
velopment of atherosclerotic lesions by re-
ducing inducible nitric oxide synthesis with 
concomitant macrophage proliferation.  
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